ReviewCurrent hematologic malignancy reports2024

Disparities in Clinical Trial Enrollment- Focus on CAR-T and Bispecific Antibody Therapies.

Nadia Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.